Skip to main content

Exit WCAG Theme

Switch to Non-ADA Website

Accessibility Options

Select Text Sizes

Select Text Color

Website Accessibility Information Close Options
Close Menu
Spencer Morgan Law, Spencer G. Morgan, Attorney At Law Miami Personal Injury Lawyer
  • Call Now 24/7 for a Free Consultation
  • ~
  • Firm Direct Text 786-353-0688
  • ~
  • No Fees or Costs If No Recovery
  • ~
  • Toll Free: 866-667-4265
  • ~
  • En Español

Miami Proton Pump Inhibitor Lawyer

Proton pump inhibitors were once marketed as a safe, long-term solution for acid reflux, ulcers, and related digestive conditions. For millions of Americans, these drugs became a daily staple, taken for years without much concern. What pharmaceutical manufacturers knew, and what patients were often not told, is that long-term use of these medications carries documented risks of serious kidney damage, bone fractures, cardiovascular events, and other severe complications. As a Miami proton pump inhibitor lawyer, Spencer Morgan Law represents people throughout South Florida who took these drugs in good faith and suffered consequences that a proper warning could have helped them avoid.

What the Research Has Revealed About PPI Risks

Drugs like omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole are sold under brand names including Nexium, Prilosec, Prevacid, Protonix, and Aciphex, among others. These are among the most widely prescribed and purchased over-the-counter medications in the country. For years, prescribers and patients were given little reason to think twice about extended use.

The scientific literature has since painted a different picture. Multiple large-scale studies have linked prolonged PPI use to conditions that can permanently alter a patient’s quality of life. The injuries that form the basis of most PPI litigation include:

  • Chronic kidney disease and acute interstitial nephritis, even in patients with no prior kidney problems
  • End-stage renal disease requiring dialysis or transplant following long-term use
  • Hypomagnesemia, a dangerous drop in magnesium levels that affects heart rhythm and muscle function
  • Increased risk of osteoporosis-related fractures, particularly of the hip, wrist, and spine
  • Clostridium difficile and other serious gastrointestinal infections linked to disruption of stomach acid
  • Dementia and cognitive decline associations identified in some population-level studies

The core legal issue is not whether these drugs cause harm in every case but whether the companies that manufactured and distributed them gave adequate warning of known risks. Drug manufacturers have a duty under federal and Florida law to provide warnings that are commensurate with what the scientific and medical community understands about a medication’s risk profile. When internal research, post-market surveillance data, or published studies reveal dangers that are not reflected in labeling or in communications to prescribers, there is potential liability. The fact that regulatory agencies may have approved a drug does not insulate a manufacturer from failure-to-warn claims when new evidence emerges and warnings are not updated accordingly.

How These Cases Are Built and What Needs to Be Proved

Pharmaceutical litigation is not a simple matter of showing that someone took a drug and got sick. There are specific legal elements that a plaintiff must establish, and the evidentiary demands are substantial. The first layer of any PPI claim is medical causation: linking the plaintiff’s diagnosis to PPI use in a way that is supported by treating physicians and, in most cases, by expert medical testimony. This requires a careful review of medical records going back years, an analysis of the duration and dosage of PPI use, and a ruling out of alternative causes for the kidney disease or other condition at issue.

The second layer involves what the manufacturer knew and when they knew it. Attorneys handling these cases review internal company communications, regulatory submissions, and the evolution of labeling over time. When a company had access to data suggesting a serious risk and chose not to update its warnings promptly or meaningfully, that decision forms the heart of the failure-to-warn theory. Florida’s product liability framework recognizes that pharmaceutical companies are held to the standard of an expert in their field, meaning they are charged with knowledge of information that was reasonably available to them through the exercise of proper scientific diligence.

Most PPI cases are pursued in coordinated federal multidistrict litigation or in state court consolidations, depending on the specific drug and the current procedural posture. Spencer Morgan Law monitors the status of pending litigation and coordinates with clients to ensure their claims are filed within applicable deadlines. Florida’s statute of limitations for personal injury claims generally requires filing within four years from the date of injury or from the date the injury was, or reasonably should have been, discovered. In practice, the discovery rule matters enormously in pharmaceutical cases, where patients often do not connect their diagnosis to a medication they took years earlier.

The Types of Damages That Apply in PPI Claims

When a manufacturer fails to adequately warn patients and physicians about the risks of a prescription or over-the-counter medication, the damages available reflect the full scope of what the plaintiff has lost or will lose. For patients who developed chronic kidney disease from long-term PPI use, those losses can be substantial and lifelong.

Medical expenses form the baseline of any claim. For kidney disease, this includes nephrology consultations, hospitalizations, laboratory monitoring, and in the most serious cases, the cost of dialysis treatment, which can run into hundreds of thousands of dollars over a patient’s lifetime, or organ transplantation. Future medical expenses are calculated with help from medical experts and life-care planners who project the ongoing cost of the condition.

Beyond medical costs, a PPI claim can include compensation for lost income and diminished earning capacity, particularly where dialysis schedules or physical limitations have affected the plaintiff’s ability to work. Pain and suffering damages account for the physical experience of kidney disease and related complications, including the fatigue, dietary restrictions, and treatment burden that accompany chronic renal failure. Where a spouse or close family member has been affected by the plaintiff’s condition, a loss of consortium claim may also be available under Florida law.

In cases where there is evidence that a manufacturer deliberately concealed or minimized known risks, punitive damages may also be on the table. Florida’s punitive damages standard requires a showing of intentional misconduct or gross negligence, a threshold that pharmaceutical cases involving the suppression of safety data have sometimes met.

Answers to Questions Miami Patients Often Ask About PPI Litigation

I took a PPI for years and was recently diagnosed with kidney disease. How do I know if I have a case?

The starting point is understanding the timeline. If you used a proton pump inhibitor regularly over a period of months or years and have since been diagnosed with chronic kidney disease, acute kidney injury, or end-stage renal disease, that combination warrants legal review. An attorney can help evaluate whether the medical records support a causation argument and whether your claim falls within the applicable statute of limitations.

My doctor prescribed this medication. Does that mean I cannot sue the manufacturer?

No. A claim against a drug manufacturer does not require that your physician did anything wrong. The theory in most PPI cases is that the manufacturer failed to give prescribers adequate warning about kidney risks, which means physicians were writing prescriptions without full knowledge of what their patients were being exposed to. The manufacturer’s duty to warn runs to both physicians and, in some contexts, directly to patients.

Does it matter whether I took a prescription PPI or an over-the-counter version?

It can matter to some degree in terms of which legal theories apply and which entity bears responsibility. However, the fundamental question of whether the warnings provided to consumers were adequate applies regardless of whether the drug was prescription or over-the-counter. If you took a drug like Prilosec OTC or Nexium 24HR and developed a serious condition, the circumstances may still support a claim.

Are these cases handled individually or as part of a class action?

Most PPI cases involving kidney disease have been filed as individual lawsuits that are coordinated in multidistrict litigation rather than as a class action. This distinction matters to you as a plaintiff because your damages are specific to your own injuries and circumstances, rather than being shared across a large group. Coordinated litigation allows courts to handle common legal and factual questions efficiently while preserving each plaintiff’s individual claim for damages.

What does it cost to pursue a PPI claim?

Spencer Morgan Law handles these cases on a contingency fee basis. There is no fee unless a recovery is obtained on your behalf. Litigation costs are advanced by the firm and recovered from any settlement or judgment. You will not be asked to pay out of pocket to have your case evaluated or pursued.

How long does PPI litigation typically take?

Pharmaceutical mass tort litigation moves on its own timeline, which is often longer than a standard personal injury case. Cases in multidistrict litigation may take several years to resolve, either through a negotiated global settlement or through individual trial proceedings. This is not a reason to delay, however, because early filing preserves your rights and ensures your claim is properly positioned within the litigation.

What records should I gather before contacting an attorney?

Gather your prescription history or records of over-the-counter PPI purchases, your medical records documenting any kidney diagnosis, and documentation from your treating nephrologist. The more complete a picture the records tell about your PPI use and subsequent diagnosis, the more efficiently an attorney can evaluate your potential claim.

Talk to a Miami PPI Attorney About Your Situation

Spencer Morgan Law has represented injury victims in South Florida since 2001, pursuing claims that require persistence, resources, and a willingness to go up against well-funded defendants. A Miami proton pump inhibitor attorney at the firm can review your medical history and help you understand whether the facts of your case support a claim. Schedule a confidential consultation today to discuss what happened, what your options are, and what pursuing a claim would involve for you specifically.

Share This Page:

Please fill out the form provided and one of our dedicated staff members will assist you in scheduling a free consultation.

By submitting this form I acknowledge that form submissions via this website do not create an attorney-client relationship, and any information I send is not protected by attorney-client privilege.

Skip footer and go back to main navigation